Tag Archives: AERI

Needham Sticks to Their Buy Rating for Aerie Pharma (AERI)

Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a price target of $40.00. The company’s shares closed last Monday at $13.50, close to its 52-week low of $10.80. According to

Merrill Lynch Maintains a Hold Rating on Aerie Pharma (AERI)

In a report released today, Jason Gerberry from Merrill Lynch maintained a Hold rating on Aerie Pharma (AERI – Research Report), with a price target of $17.00. The company’s shares closed last Monday at $11.30, close to its 52-week low

Analysts Are Bullish on Top Healthcare Stocks: Aerie Pharma (AERI), Homology Medicines (FIXX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma (AERI – Research Report) and Homology Medicines (FIXX – Research Report) with bullish sentiments. Aerie Pharma (AERI) Mizuho Securities analyst

Analysts Conflicted on These Healthcare Names: Aerie Pharma (NASDAQ: AERI) and Radius Health (NASDAQ: RDUS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aerie Pharma (AERI – Research Report) and Radius Health (RDUS – Research Report). Aerie Pharma (AERI) In a report released today, Difei Yang

Needham Sticks to Its Buy Rating for Aerie Pharma (AERI)

Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) on February 14 and set a price target of $40.00. The company’s shares closed last Monday at $19.45, close to its 52-week low of $17.15.

Wednesday’s Midday Stock Update: Whiting Petroleum (WLL), Cormedix (CRMD), Aerie Pharma (AERI), BP Prudhoe Bay (BPT)

So far Wednesday, January 1, NASDAQ is up 1.86% and the S&P is up 1.33%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Whiting Petroleum (WLL – Research Report), Cormedix (CRMD – Research